1 unknown. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Conditions: new trials by email Literature Review of Conditions trials Research Report on Conditions
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Decitabine+BUCY vs BUCY Conditioning Regimen for MLL+ Acute Leukemia Undergoing Allo-HSCT Decitabine, Busulfan (BU), Cyclophosphamide (CY) - Allogeneic Hematopoietic Stem Cell Transplantation, Conditions | Phase 2 / Phase 3 | Unknown | Nanfang Hospital, Southern Medical University | 122 | 2018-07-01 | 2018-07-24 |
Disease (1)
Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Busulfan (1) · Cyclophosphamide (1) · Decitabine (1)
Nanfang Hospital, Southern Medical University (1)
China (1)
Qifa Liu (1)